Licensed pharmacist，
Graduated from Shenyang Pharmaceutical University, Master of law， Nankai University.

IP Manager，
Science and Technology Development Center of Chinese Pharmaceutical Association.

Marketing Director，
in manufacturing enterprises.

Business Director，
Pharmaceutical Research Institute of Founder Group Southwest Synthesis and Daxin Pharmaceutical's merger planning.

Investerment Director,
Jiangxi Jimin Pharma Group， responsible for strategic planning and mergers and acquisitions.

General Manager,Sinomed ,
Engaged in R&D and acquisition and consulting work for 10 years, currently engaged in project evaluation, Strategic planning and technical evaluation.

Farmiliar with consulting pharmaceutical companies raise investment planning and corporate product strategic planning work, and projects acquisition evaluation.

Presided over the compilation of "China's New Drug Review" series of publications, for the "China Medical News", "China High-tech Industrial Herald · New Medicine Weekly" "self-medication" and other articles or magazine.